CovidFranceV1, Main, Exploration, bibRecord, 000817

Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations.

Identifieur interne : 000817 ( Main/Exploration ); précédent : 000816; suivant : 000818

Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations.

Auteurs : Christen R. Elledge [États-Unis] ; Sushil Beriwal [États-Unis] ; Cyrus Chargari [France] ; Supriya Chopra [Inde] ; Beth A. Erickson [États-Unis] ; David K. Gaffney [États-Unis] ; Anuja Jhingran [États-Unis] ; Ann H. Klopp [États-Unis] ; William Small [États-Unis] ; Catheryn M. Yashar [États-Unis] ; Akila N. Viswanathan [États-Unis]

Source :

Gynecologic oncology [ 1095-6859 ] ; 2020.

RBID : pubmed:32563593

Descripteurs français

KwdFr :
- Betacoronavirus (isolement et purification), Femelle (MeSH), Humains (MeSH), Infections à coronavirus (prévention et contrôle), Infections à coronavirus (transmission), Infections à coronavirus (épidémiologie), Pandémies (prévention et contrôle), Pneumopathie virale (prévention et contrôle), Pneumopathie virale (transmission), Pneumopathie virale (épidémiologie), Prévention des infections (méthodes), Prévention des infections (normes), Radio-oncologie (méthodes), Radio-oncologie (normes), Tumeurs de l'appareil génital féminin (radiothérapie), Tumeurs de l'appareil génital féminin (virologie).
MESH :
- isolement et purification : Betacoronavirus.
- méthodes : Prévention des infections, Radio-oncologie.
- normes : Prévention des infections, Radio-oncologie.
- prévention et contrôle : Infections à coronavirus, Pandémies, Pneumopathie virale.
- radiothérapie : Tumeurs de l'appareil génital féminin.
- virologie : Tumeurs de l'appareil génital féminin.
- épidémiologie : Infections à coronavirus, Pneumopathie virale.
- Femelle, Humains.

English descriptors

KwdEn :
- Betacoronavirus (isolation & purification), Coronavirus Infections (epidemiology), Coronavirus Infections (prevention & control), Coronavirus Infections (transmission), Female (MeSH), Genital Neoplasms, Female (radiotherapy), Genital Neoplasms, Female (virology), Humans (MeSH), Infection Control (methods), Infection Control (standards), Pandemics (prevention & control), Pneumonia, Viral (epidemiology), Pneumonia, Viral (prevention & control), Pneumonia, Viral (transmission), Radiation Oncology (methods), Radiation Oncology (standards).
MESH :
- epidemiology : Coronavirus Infections, Pneumonia, Viral.
- isolation & purification : Betacoronavirus.
- methods : Infection Control, Radiation Oncology.
- prevention & control : Coronavirus Infections, Pandemics, Pneumonia, Viral.
- radiotherapy : Genital Neoplasms, Female.
- standards : Infection Control, Radiation Oncology.
- transmission : Coronavirus Infections, Pneumonia, Viral.
- virology : Genital Neoplasms, Female.
- Female, Humans.

Abstract

OBJECTIVE

To develop expert consensus recommendations regarding radiation therapy for gynecologic malignancies during the COVID-19 pandemic.

METHODS

An international committee of ten experts in gynecologic radiation oncology convened to provide consensus recommendations for patients with gynecologic malignancies referred for radiation therapy. Treatment priority groups were established. A review of the relevant literature was performed and different clinical scenarios were categorized into three priority groups. For each stage and clinical scenario in cervical, endometrial, vulvar, vaginal and ovarian cancer, specific recommendations regarding dose, technique, and timing were provided by the panel.

RESULTS

Expert review and discussion generated consensus recommendations to guide radiation oncologists treating gynecologic malignancies during the COVID-19 pandemic. Priority scales for cervical, endometrial, vulvar, vaginal, and ovarian cancers are presented. Both radical and palliative treatments are discussed. Management of COVID-19 positive patients is considered. Hypofractionated radiation therapy should be used when feasible and recommendations regarding radiation dose, timing, and technique have been provided for external beam and brachytherapy treatments. Concurrent chemotherapy may be limited in some countries, and consideration of radiation alone is recommended.

CONCLUSIONS

The expert consensus recommendations provide guidance for delivering radiation therapy during the COVID-19 pandemic. Specific recommendations have been provided for common clinical scenarios encountered in gynecologic radiation oncology with a focus on strategies to reduce patient and staff exposure to COVID-19.

DOI: 10.1016/j.ygyno.2020.06.486
PubMed: 32563593
PubMed Central: PMC7294297

Affiliations:

France, Inde, États-Unis
Californie, Illinois, Maryland, Pennsylvanie, Texas, Utah, Wisconsin
Villejuif

Links toward previous steps (curation, corpus...)

to stream Main, to step Corpus: 000C84
to stream Main, to step Curation: 000C84

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations.</title>
<author><name sortKey="Elledge, Christen R" sort="Elledge, Christen R" uniqKey="Elledge C" first="Christen R" last="Elledge">Christen R. Elledge</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Beriwal, Sushil" sort="Beriwal, Sushil" uniqKey="Beriwal S" first="Sushil" last="Beriwal">Sushil Beriwal</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chargari, Cyrus" sort="Chargari, Cyrus" uniqKey="Chargari C" first="Cyrus" last="Chargari">Cyrus Chargari</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif</wicri:regionArea>
<placeName><settlement type="city">Villejuif</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chopra, Supriya" sort="Chopra, Supriya" uniqKey="Chopra S" first="Supriya" last="Chopra">Supriya Chopra</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai</wicri:regionArea>
<wicri:noRegion>Navi Mumbai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Erickson, Beth A" sort="Erickson, Beth A" uniqKey="Erickson B" first="Beth A" last="Erickson">Beth A. Erickson</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI</wicri:regionArea>
<placeName><region type="state">Wisconsin</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gaffney, David K" sort="Gaffney, David K" uniqKey="Gaffney D" first="David K" last="Gaffney">David K. Gaffney</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT</wicri:regionArea>
<placeName><region type="state">Utah</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jhingran, Anuja" sort="Jhingran, Anuja" uniqKey="Jhingran A" first="Anuja" last="Jhingran">Anuja Jhingran</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Klopp, Ann H" sort="Klopp, Ann H" uniqKey="Klopp A" first="Ann H" last="Klopp">Ann H. Klopp</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Small, William" sort="Small, William" uniqKey="Small W" first="William" last="Small">William Small</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yashar, Catheryn M" sort="Yashar, Catheryn M" uniqKey="Yashar C" first="Catheryn M" last="Yashar">Catheryn M. Yashar</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, University of California San Diego, San Diego, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, University of California San Diego, San Diego, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Viswanathan, Akila N" sort="Viswanathan, Akila N" uniqKey="Viswanathan A" first="Akila N" last="Viswanathan">Akila N. Viswanathan</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: anv@jhu.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2020">2020</date>
<idno type="RBID">pubmed:32563593</idno>
<idno type="pmid">32563593</idno>
<idno type="doi">10.1016/j.ygyno.2020.06.486</idno>
<idno type="pmc">PMC7294297</idno>
<idno type="wicri:Area/Main/Corpus">000C84</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Corpus" wicri:corpus="PubMed">000C84</idno>
<idno type="wicri:Area/Main/Curation">000C84</idno>
<idno type="wicri:explorRef" wicri:stream="Main" wicri:step="Curation">000C84</idno>
<idno type="wicri:Area/Main/Exploration">000C84</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations.</title>
<author><name sortKey="Elledge, Christen R" sort="Elledge, Christen R" uniqKey="Elledge C" first="Christen R" last="Elledge">Christen R. Elledge</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Beriwal, Sushil" sort="Beriwal, Sushil" uniqKey="Beriwal S" first="Sushil" last="Beriwal">Sushil Beriwal</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA</wicri:regionArea>
<placeName><region type="state">Pennsylvanie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chargari, Cyrus" sort="Chargari, Cyrus" uniqKey="Chargari C" first="Cyrus" last="Chargari">Cyrus Chargari</name>
<affiliation wicri:level="3"><nlm:affiliation>Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif</wicri:regionArea>
<placeName><settlement type="city">Villejuif</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Chopra, Supriya" sort="Chopra, Supriya" uniqKey="Chopra S" first="Supriya" last="Chopra">Supriya Chopra</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, India.</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai</wicri:regionArea>
<wicri:noRegion>Navi Mumbai</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Erickson, Beth A" sort="Erickson, Beth A" uniqKey="Erickson B" first="Beth A" last="Erickson">Beth A. Erickson</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI</wicri:regionArea>
<placeName><region type="state">Wisconsin</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Gaffney, David K" sort="Gaffney, David K" uniqKey="Gaffney D" first="David K" last="Gaffney">David K. Gaffney</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT</wicri:regionArea>
<placeName><region type="state">Utah</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Jhingran, Anuja" sort="Jhingran, Anuja" uniqKey="Jhingran A" first="Anuja" last="Jhingran">Anuja Jhingran</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Klopp, Ann H" sort="Klopp, Ann H" uniqKey="Klopp A" first="Ann H" last="Klopp">Ann H. Klopp</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX</wicri:regionArea>
<placeName><region type="state">Texas</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Small, William" sort="Small, William" uniqKey="Small W" first="William" last="Small">William Small</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL</wicri:regionArea>
<placeName><region type="state">Illinois</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Yashar, Catheryn M" sort="Yashar, Catheryn M" uniqKey="Yashar C" first="Catheryn M" last="Yashar">Catheryn M. Yashar</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology, University of California San Diego, San Diego, CA, USA.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology, University of California San Diego, San Diego, CA</wicri:regionArea>
<placeName><region type="state">Californie</region>
</placeName>
</affiliation>
</author>
<author><name sortKey="Viswanathan, Akila N" sort="Viswanathan, Akila N" uniqKey="Viswanathan A" first="Akila N" last="Viswanathan">Akila N. Viswanathan</name>
<affiliation wicri:level="2"><nlm:affiliation>Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: anv@jhu.edu.</nlm:affiliation>
<country xml:lang="fr">États-Unis</country>
<wicri:regionArea>Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD</wicri:regionArea>
<placeName><region type="state">Maryland</region>
</placeName>
</affiliation>
</author>
</analytic>
<series><title level="j">Gynecologic oncology</title>
<idno type="eISSN">1095-6859</idno>
<imprint><date when="2020" type="published">2020</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Betacoronavirus (isolation & purification)</term>
<term>Coronavirus Infections (epidemiology)</term>
<term>Coronavirus Infections (prevention & control)</term>
<term>Coronavirus Infections (transmission)</term>
<term>Female (MeSH)</term>
<term>Genital Neoplasms, Female (radiotherapy)</term>
<term>Genital Neoplasms, Female (virology)</term>
<term>Humans (MeSH)</term>
<term>Infection Control (methods)</term>
<term>Infection Control (standards)</term>
<term>Pandemics (prevention & control)</term>
<term>Pneumonia, Viral (epidemiology)</term>
<term>Pneumonia, Viral (prevention & control)</term>
<term>Pneumonia, Viral (transmission)</term>
<term>Radiation Oncology (methods)</term>
<term>Radiation Oncology (standards)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Betacoronavirus (isolement et purification)</term>
<term>Femelle (MeSH)</term>
<term>Humains (MeSH)</term>
<term>Infections à coronavirus (prévention et contrôle)</term>
<term>Infections à coronavirus (transmission)</term>
<term>Infections à coronavirus (épidémiologie)</term>
<term>Pandémies (prévention et contrôle)</term>
<term>Pneumopathie virale (prévention et contrôle)</term>
<term>Pneumopathie virale (transmission)</term>
<term>Pneumopathie virale (épidémiologie)</term>
<term>Prévention des infections (méthodes)</term>
<term>Prévention des infections (normes)</term>
<term>Radio-oncologie (méthodes)</term>
<term>Radio-oncologie (normes)</term>
<term>Tumeurs de l'appareil génital féminin (radiothérapie)</term>
<term>Tumeurs de l'appareil génital féminin (virologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Betacoronavirus</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Infection Control</term>
<term>Radiation Oncology</term>
</keywords>
<keywords scheme="MESH" qualifier="méthodes" xml:lang="fr"><term>Prévention des infections</term>
<term>Radio-oncologie</term>
</keywords>
<keywords scheme="MESH" qualifier="normes" xml:lang="fr"><term>Prévention des infections</term>
<term>Radio-oncologie</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pandemics</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="prévention et contrôle" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pandémies</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Genital Neoplasms, Female</term>
</keywords>
<keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs de l'appareil génital féminin</term>
</keywords>
<keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Infection Control</term>
<term>Radiation Oncology</term>
</keywords>
<keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Coronavirus Infections</term>
<term>Pneumonia, Viral</term>
</keywords>
<keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Tumeurs de l'appareil génital féminin</term>
</keywords>
<keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Genital Neoplasms, Female</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Infections à coronavirus</term>
<term>Pneumopathie virale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Female</term>
<term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Femelle</term>
<term>Humains</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en"><p><b>OBJECTIVE</b>
</p>
<p>To develop expert consensus recommendations regarding radiation therapy for gynecologic malignancies during the COVID-19 pandemic.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>METHODS</b>
</p>
<p>An international committee of ten experts in gynecologic radiation oncology convened to provide consensus recommendations for patients with gynecologic malignancies referred for radiation therapy. Treatment priority groups were established. A review of the relevant literature was performed and different clinical scenarios were categorized into three priority groups. For each stage and clinical scenario in cervical, endometrial, vulvar, vaginal and ovarian cancer, specific recommendations regarding dose, technique, and timing were provided by the panel.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>RESULTS</b>
</p>
<p>Expert review and discussion generated consensus recommendations to guide radiation oncologists treating gynecologic malignancies during the COVID-19 pandemic. Priority scales for cervical, endometrial, vulvar, vaginal, and ovarian cancers are presented. Both radical and palliative treatments are discussed. Management of COVID-19 positive patients is considered. Hypofractionated radiation therapy should be used when feasible and recommendations regarding radiation dose, timing, and technique have been provided for external beam and brachytherapy treatments. Concurrent chemotherapy may be limited in some countries, and consideration of radiation alone is recommended.</p>
</div>
<div type="abstract" xml:lang="en"><p><b>CONCLUSIONS</b>
</p>
<p>The expert consensus recommendations provide guidance for delivering radiation therapy during the COVID-19 pandemic. Specific recommendations have been provided for common clinical scenarios encountered in gynecologic radiation oncology with a focus on strategies to reduce patient and staff exposure to COVID-19.</p>
</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32563593</PMID>
<DateCompleted><Year>2020</Year>
<Month>08</Month>
<Day>26</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>09</Month>
<Day>14</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1095-6859</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>158</Volume>
<Issue>2</Issue>
<PubDate><Year>2020</Year>
<Month>08</Month>
</PubDate>
</JournalIssue>
<Title>Gynecologic oncology</Title>
<ISOAbbreviation>Gynecol. Oncol.</ISOAbbreviation>
</Journal>
<ArticleTitle>Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations.</ArticleTitle>
<Pagination><MedlinePgn>244-253</MedlinePgn>
</Pagination>
<ELocationID EIdType="pii" ValidYN="Y">S0090-8258(20)32301-5</ELocationID>
<ELocationID EIdType="doi" ValidYN="Y">10.1016/j.ygyno.2020.06.486</ELocationID>
<Abstract><AbstractText Label="OBJECTIVE">To develop expert consensus recommendations regarding radiation therapy for gynecologic malignancies during the COVID-19 pandemic.</AbstractText>
<AbstractText Label="METHODS">An international committee of ten experts in gynecologic radiation oncology convened to provide consensus recommendations for patients with gynecologic malignancies referred for radiation therapy. Treatment priority groups were established. A review of the relevant literature was performed and different clinical scenarios were categorized into three priority groups. For each stage and clinical scenario in cervical, endometrial, vulvar, vaginal and ovarian cancer, specific recommendations regarding dose, technique, and timing were provided by the panel.</AbstractText>
<AbstractText Label="RESULTS">Expert review and discussion generated consensus recommendations to guide radiation oncologists treating gynecologic malignancies during the COVID-19 pandemic. Priority scales for cervical, endometrial, vulvar, vaginal, and ovarian cancers are presented. Both radical and palliative treatments are discussed. Management of COVID-19 positive patients is considered. Hypofractionated radiation therapy should be used when feasible and recommendations regarding radiation dose, timing, and technique have been provided for external beam and brachytherapy treatments. Concurrent chemotherapy may be limited in some countries, and consideration of radiation alone is recommended.</AbstractText>
<AbstractText Label="CONCLUSIONS">The expert consensus recommendations provide guidance for delivering radiation therapy during the COVID-19 pandemic. Specific recommendations have been provided for common clinical scenarios encountered in gynecologic radiation oncology with a focus on strategies to reduce patient and staff exposure to COVID-19.</AbstractText>
<CopyrightInformation>Copyright © 2020 Elsevier Inc. All rights reserved.</CopyrightInformation>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Elledge</LastName>
<ForeName>Christen R</ForeName>
<Initials>CR</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Beriwal</LastName>
<ForeName>Sushil</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, University of Pittsburgh Medical Center, Hillman Cancer Center, Pittsburgh, PA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chargari</LastName>
<ForeName>Cyrus</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Chopra</LastName>
<ForeName>Supriya</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, Advanced Centre for Treatment, Research and Education in Cancer, Tata Memorial Centre, Homi Bhabha National Institute, Kharghar, Navi Mumbai, India.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Erickson</LastName>
<ForeName>Beth A</ForeName>
<Initials>BA</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Gaffney</LastName>
<ForeName>David K</ForeName>
<Initials>DK</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Jhingran</LastName>
<ForeName>Anuja</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Klopp</LastName>
<ForeName>Ann H</ForeName>
<Initials>AH</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Small</LastName>
<ForeName>William</ForeName>
<Initials>W</Initials>
<Suffix>Jr</Suffix>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, Loyola University Chicago, Stritch School of Medicine, Maywood, IL, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Yashar</LastName>
<ForeName>Catheryn M</ForeName>
<Initials>CM</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology, University of California San Diego, San Diego, CA, USA.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Viswanathan</LastName>
<ForeName>Akila N</ForeName>
<Initials>AN</Initials>
<AffiliationInfo><Affiliation>Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD, USA. Electronic address: anv@jhu.edu.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D017065">Practice Guideline</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2020</Year>
<Month>06</Month>
<Day>15</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Gynecol Oncol</MedlineTA>
<NlmUniqueID>0365304</NlmUniqueID>
<ISSNLinking>0090-8258</ISSNLinking>
</MedlineJournalInfo>
<SupplMeshList><SupplMeshName Type="Disease" UI="C000657245">COVID-19</SupplMeshName>
<SupplMeshName Type="Organism" UI="C000656484">severe acute respiratory syndrome coronavirus 2</SupplMeshName>
</SupplMeshList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000073640" MajorTopicYN="N">Betacoronavirus</DescriptorName>
<QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018352" MajorTopicYN="N">Coronavirus Infections</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005833" MajorTopicYN="N">Genital Neoplasms, Female</DescriptorName>
<QualifierName UI="Q000532" MajorTopicYN="Y">radiotherapy</QualifierName>
<QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="N">standards</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D011024" MajorTopicYN="N">Pneumonia, Viral</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="Y">prevention & control</QualifierName>
<QualifierName UI="Q000635" MajorTopicYN="N">transmission</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018787" MajorTopicYN="N">Radiation Oncology</DescriptorName>
<QualifierName UI="Q000379" MajorTopicYN="Y">methods</QualifierName>
<QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName>
</MeshHeading>
</MeshHeadingList>
<CoiStatement>Declaration of Competing Interest Christen Elledge, Supriya Chopra, Beth Erikson, David Gaffney, Anuja Jhingran, Ann Klopp, and Catherine Yashar have nothing to disclose. Akila Viswanathan is the principal investigator of NIH R01 CA237005. Sushil Beriwal is a consultant for Varian and Medical Director of Via Oncology, outside the submitted work. Cyrus Chargari receives grant funding from Roche, personal fees from Merck Sharp & Dohme Corp., Elekta, and GlaxoSmithKline, as well as non-financial support from TherAguiX and GlaxoSmithKline, all outside the submitted work. William Small is the co-chair of the NRG Gyn Committee, has served on an advisory board for Merck, and has received honoraria for invited talks from Carl Zeiss Meditech, outside the submitted work.</CoiStatement>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year>
<Month>04</Month>
<Day>28</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2020</Year>
<Month>06</Month>
<Day>10</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2020</Year>
<Month>6</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2020</Year>
<Month>8</Month>
<Day>28</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2020</Year>
<Month>6</Month>
<Day>22</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">32563593</ArticleId>
<ArticleId IdType="pii">S0090-8258(20)32301-5</ArticleId>
<ArticleId IdType="doi">10.1016/j.ygyno.2020.06.486</ArticleId>
<ArticleId IdType="pmc">PMC7294297</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>France</li>
<li>Inde</li>
<li>États-Unis</li>
</country>
<region><li>Californie</li>
<li>Illinois</li>
<li>Maryland</li>
<li>Pennsylvanie</li>
<li>Texas</li>
<li>Utah</li>
<li>Wisconsin</li>
</region>
<settlement><li>Villejuif</li>
</settlement>
</list>
<tree><country name="États-Unis"><region name="Maryland"><name sortKey="Elledge, Christen R" sort="Elledge, Christen R" uniqKey="Elledge C" first="Christen R" last="Elledge">Christen R. Elledge</name>
</region>
<name sortKey="Beriwal, Sushil" sort="Beriwal, Sushil" uniqKey="Beriwal S" first="Sushil" last="Beriwal">Sushil Beriwal</name>
<name sortKey="Erickson, Beth A" sort="Erickson, Beth A" uniqKey="Erickson B" first="Beth A" last="Erickson">Beth A. Erickson</name>
<name sortKey="Gaffney, David K" sort="Gaffney, David K" uniqKey="Gaffney D" first="David K" last="Gaffney">David K. Gaffney</name>
<name sortKey="Jhingran, Anuja" sort="Jhingran, Anuja" uniqKey="Jhingran A" first="Anuja" last="Jhingran">Anuja Jhingran</name>
<name sortKey="Klopp, Ann H" sort="Klopp, Ann H" uniqKey="Klopp A" first="Ann H" last="Klopp">Ann H. Klopp</name>
<name sortKey="Small, William" sort="Small, William" uniqKey="Small W" first="William" last="Small">William Small</name>
<name sortKey="Viswanathan, Akila N" sort="Viswanathan, Akila N" uniqKey="Viswanathan A" first="Akila N" last="Viswanathan">Akila N. Viswanathan</name>
<name sortKey="Yashar, Catheryn M" sort="Yashar, Catheryn M" uniqKey="Yashar C" first="Catheryn M" last="Yashar">Catheryn M. Yashar</name>
</country>
<country name="France"><noRegion><name sortKey="Chargari, Cyrus" sort="Chargari, Cyrus" uniqKey="Chargari C" first="Cyrus" last="Chargari">Cyrus Chargari</name>
</noRegion>
</country>
<country name="Inde"><noRegion><name sortKey="Chopra, Supriya" sort="Chopra, Supriya" uniqKey="Chopra S" first="Supriya" last="Chopra">Supriya Chopra</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/CovidFranceV1/Data/Main/Exploration

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000817 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 000817 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    CovidFranceV1
   |flux=    Main
   |étape=   Exploration
   |type=    RBID
   |clé=     pubmed:32563593
   |texte=   Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i   -Sk "pubmed:32563593" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd   \
       | NlmPubMed2Wicri -a CovidFranceV1

This area was generated with Dilib version V0.6.37.
Data generation: Tue Oct 6 23:31:36 2020. Site generation: Fri Feb 12 22:48:37 2021

	Serveur d'exploration sur la COVID en France
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration sur la COVID en France

Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations.

Radiation therapy for gynecologic malignancies during the COVID-19 pandemic: International expert consensus recommendations.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki